NGR-hTNF plus chemotherapy as first-line therapy of non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Gregorc, Vanesa
Zilembo, Nicoletta
Grossi, Francesco
De Pas, Tommaso M.
Rossoni, Gilda
Pietrantonio, Filippo
Rijavec, Erika
Giovannini, Monica
Citterio, Giovanni
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[2] IRCCSS Fdn Ist Nazl Tumori, Dept Oncol, Milan, Italy
[3] Natl Canc Res Ctr, Lung Canc Unit, Genoa, Italy
[4] Ist Europeo Oncol, Unit Resp Tract & Sarcomas, Milan, Italy
[5] MolMed, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7581
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FRONT-LINE CHEMOTHERAPY WITH OR WITHOUT NGR-HTNF IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    De Pas, T.
    Pietrantonio, F.
    Giovannini, M.
    Rossoni, G.
    Bulotta, A.
    Lambiase, A.
    Bordignon, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 410 - 410
  • [2] NGR-HTNF PLUS DOXORUBICIN IN RELAPSED SMALL CELL LUNG CANCER (SCLC)
    Novello, Silvia
    Cavina, Raffaele
    Vigano, Maria G.
    Grossi, Francesco
    Santoro, Armando
    Gregorc, Vanesa
    Scagliotti, Giorgio
    Garassino, Isabella
    Rossoni, Gilda
    Levra, Matteo G.
    Genova, Carlo
    Lambiase, Antonio
    Bordignon, Claudio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1348 - S1349
  • [3] Randomized phase II trial of NGR-hTNF in combination with standard chemotherapy in previously untreated non-small cell lung cancer (NSCLC).
    Gregorc, Vanesa
    Zilembo, Nicoletta
    Grossi, Francesco
    De Pas, Tommaso M.
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Citterio, Giovanni
    Lambiase, Antonio
    Bordignon, Claudio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) - Preliminary Results
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Citterio, G.
    Platania, M.
    Lambiase, A.
    Bordignon, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S596 - S596
  • [5] Randomized, phase II trial of NGR-hTNF and chemotherapy in chemotherapy-naive patients with non-small cell lung cancer (NSCLC): Preliminary results.
    Gregorc, V.
    Zilembo, N.
    Grossi, F.
    Rossoni, G.
    Pietrantonio, F.
    Rijavec, E.
    Bulotta, A.
    Vitali, M.
    Barletta, G.
    Bergamaschi, L.
    Platania, M.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] RANDOMIZED PHASE II TRIAL OF NGR-HTNF AND CHEMOTHERAPY IN CHEMO-NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS.
    Gregorc, Vanesa
    Zilembo, N.
    Grossi, Francesco
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Bulotta, Alessandra
    Vitali, Milena
    Barletta, Giulia
    Bergamaschi, Luca
    Platania, Marco
    Lambiase, Antonio
    Bordignon, Claudio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S661 - S662
  • [7] NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer
    Gregorc, Vanesa
    Cavina, Raffaele
    Novello, Sivia
    Grossi, Francesco
    Lazzari, Chiara
    Capelletto, Enrica
    Genova, Carlo
    Salini, Giulia
    Lambiase, Antonio
    Santoro, Armando
    [J]. ONCOLOGIST, 2018, 23 (10): : 1133 - +
  • [8] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    [J]. ONKOLOGIE, 2003, 26 : 26 - 32
  • [9] Cost-effectiveness of first-line pembrolizumab plus chemotherapy for metastatic squamous non-small cell lung cancer (NSCLC).
    Kim, Ashley
    Devine, Beth
    Roth, Joshua A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Prognosis of Advanced Non-Small Cell Lung Cancer (NSCLC) Refractory to First-Line Platinum Chemotherapy
    Ahn, Hee Kyung
    Kim, Young Saing
    Kim, Eun Young
    Kyung, Sun Young
    Kang, Shin Myung
    Cho, Eun Kyung
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S910 - S911
12345